Bank Of America Corp Keros Therapeutics, Inc. Transaction History

Bank Of America Corp

  • $1.43 Trillion
  • Q3 2025

A detailed history of Bank Of America Corp transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 226,127 shares of KROS stock, worth $3.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
226,127
Previous 295,477 23.47%
Holding current value
$3.9 Million
Previous $3.94 Million 9.31%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$13.34 - $16.05 $925,129 - $1.11 Million
-69,350 Reduced 23.47%
226,127 $3.58 Million
Q2 2025

Aug 14, 2025
BUY
$9.55 - $15.11 $1.34 Million - $2.11 Million
139,865 Added 89.88%
295,477 $3.94 Million
Q1 2025

May 15, 2025
SELL
$10.15 - $16.1 $59,428 - $94,265
-5,855 Reduced 3.63%
155,612 $1.59 Million
Q4 2024

Feb 14, 2025
SELL
$15.64 - $70.0 $150,206 - $672,280
-9,604 Reduced 5.61%
161,467 $2.56 Million
Q3 2024

Nov 14, 2024
SELL
$41.68 - $58.07 $330,230 - $460,088
-7,923 Reduced 4.43%
171,071 $9.93 Million
Q2 2024

Aug 14, 2024
BUY
$44.58 - $66.89 $290,527 - $435,922
6,517 Added 3.78%
178,994 $8.18 Million
Q1 2024

May 15, 2024
SELL
$41.26 - $70.48 $865,304 - $1.48 Million
-20,972 Reduced 10.84%
172,477 $11.4 Million
Q4 2023

Feb 14, 2024
BUY
$27.12 - $41.05 $3.72 Million - $5.63 Million
137,236 Added 244.14%
193,449 $7.69 Million
Q2 2023

Aug 14, 2023
SELL
$37.26 - $51.01 $724,930 - $992,450
-19,456 Reduced 25.71%
56,213 $2.26 Million
Q1 2023

May 12, 2023
BUY
$41.44 - $59.32 $403,128 - $577,064
9,728 Added 14.75%
75,669 $3.23 Million
Q4 2022

Feb 10, 2023
BUY
$39.45 - $51.77 $506,182 - $664,260
12,831 Added 24.16%
65,941 $3.17 Million
Q3 2022

Nov 14, 2022
BUY
$27.8 - $40.12 $398,679 - $575,360
14,341 Added 36.99%
53,110 $2 Million
Q2 2022

Aug 12, 2022
BUY
$26.03 - $67.04 $116,614 - $300,339
4,480 Added 13.07%
38,769 $1.07 Million
Q1 2022

May 16, 2022
BUY
$42.12 - $59.36 $123,243 - $173,687
2,926 Added 9.33%
34,289 $1.86 Million
Q4 2021

Feb 08, 2022
BUY
$36.95 - $62.89 $44,931 - $76,474
1,216 Added 4.03%
31,363 $1.84 Million
Q3 2021

Nov 15, 2021
BUY
$29.27 - $43.71 $648,447 - $968,351
22,154 Added 277.17%
30,147 $1.19 Million
Q2 2021

Sep 13, 2021
BUY
$42.4 - $70.11 $338,903 - $560,389
7,993 New
7,993 $339,000

Others Institutions Holding KROS

# of Institutions
169
Shares Held
35.4M
Call Options Held
574K
Put Options Held
325K
View Full List

About Keros Therapeutics, Inc.

KROS Quotes by TradingView
  • Ticker KROS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,757,000
  • Market Cap $445M
  • Description
  • Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...
More about KROS
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email